자산 1
CLEO ONE
ENG KOR
  • Instrument > Point-of-Care

    CLEO™ ONE

    CLEO™ ONE  |  Point-of-care molecular test device

    MFDS License No. : IVD-23-4083

    For more information, please visit www.cleo1.net
    Available soon.

    • Specifications
      Model    CLEO™ ONE
      Test capacity    1 test
      Detection channel    1 channel (FAM)
      Reaction chamber    3 well
      Connection    Blooth 5.0
      Test method    Fluorescence-Isothermal amplification
      Test sample    Nasal swab
      Operating system    Android OS, iOS
      Power supply    100 - 240V, 50/60Hz, 2A
      Dimensions (LxWxH)    72×72×104 mm (2.8″x2.8″x4.1″)
      Weight    165g (5.8 oz)
    • Features
      CLEO™ ONE Device Test Cartridge Sample tube


       
    • Technology


      • Precise Microfluidics Control (PMC) technology enables non-experts to perform point-of-care molecular self-tests. ​PMC technology can automatically move the sample to the reagent chamber without electrical or mechanical processes and minimize the volume deviation between tests by controlling liquid flow within the error range of 1 uL. 
      • In addition, PMC technology fundamentally prevents external contamination, resulting in high accuracy and reproducibility.



      • Multi-position Fluorescence Sensing (MFS) technology increases the accuracy of molecular diagnosis by reading fluorescence signals at multiple positions.
      • The MFS technology can sensitively measure the fluorescence intensity transmitted from the reaction chambers and perform multiplex analyses of fluorescence signals in real time.
      • The MFS technology can improve both point-of-care tests and self-test quality by achieving sensitivity & specificity comparable to high-performance level tests in the laboratory.

    • Test Protocol